Piscataway-based GenScript USA Inc. said Monday that the U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) for the cPass™ SARS-CoV-2 Neutralization Antibody Detection ...
In a recent study posted to the medRxiv* preprint server, researchers assessed longitudinal neutralizing antibody (nAb) responses before and after severe acute respiratory syndrome coronavirus 2 (SARS ...
An overview of how specialty laboratories use integrated scientific approaches to deliver high-quality infectious disease ...
Automation-compatible, safe assay delivers same-day results to accelerate vaccine and therapeutic antibody development PHILADELPHIA, Oct. 14, 2025 /PRNewswire/ -- Integral Molecular, a leader in ...
WOBURN, Mass., July 10, 2023 /PRNewswire/ -- Ultrasensitive immunoassays developer Spear Bio is expanding its family of NAB-Sure™ SARS Cov-2 Neutralizing Antibodies test kits. Previously released kits ...
SAN DIEGO--(BUSINESS WIRE)--AXIM Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an international healthcare diagnostic solutions development company, announced today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback